About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

BXCL501 for Agitation in Schizophrenia

NCT03708315·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Yale University

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Ability to give informed consent.
2. Male or female between 18 and 65 years of age, inclusive
3. According to DSM-V meet criteria for Schizophrenia or Schizoaffective disorder.

You may not be if

1. Current significant medical condition or other comorbidities
2. Current substance dependence
3. Women who are pregnant or breastfeeding

The record

StatusCompleted

PhasePhase 1

Taking part11

StartedMar 2020

UpdatedJul 23, 2025

Conditions

Schizophrenia Schizoaffective Disorder

Where1

Connecticut Mental Health Center
New Haven, Connecticut, United States

Clareo Health | BXCL501 for Agitation in Schizophrenia